Global Digital Breast Tomosynthesis Market - 2024-2031

Report Overview

Global Digital Breast Tomosynthesis Market reached US$ 3.5 billion in 2023 and is expected to reach US$ 6.2 billion by 2031, growing at a CAGR of 7.5% during the forecast period 2024-2031

Digital breast tomosynthesis, also known as 3D mammography, is a highly effective method for detecting breast cancer, particularly in dense breast tissue, using a series of two-dimensional images to create a three-dimensional image, unlike standard mammography which relies on 2D images.

Digital breast tomosynthesis (DBT) uses an X-ray tube to take multiple 2D images of the breast from multiple angles. This process is similar to a standard mammogram but with the breast being positioned and compressed in an arc. The images are then digitized and combined into a 3D image, which provides more detailed information, making it easier to distinguish between healthy and potentially cancerous tissue. This method offers a more accurate and detailed view of the breast, enhancing the diagnostic capabilities of breast cancer screening.

Market Dynamics: Drivers & Restraints

Rise in the prevalence of breast cancer

The rise in breast cancer globally has heightened the need for advanced diagnostic tools like Digital Breast Tomosynthesis (DBT). DBT offers more detailed imaging than traditional mammography, enabling early detection of subtle lesions. This enhanced detection is crucial for early intervention, improving patient outcomes, and reducing mortality rates. As a result, the demand for DBT systems has surged.

For instance, WHO has released a new Global Breast Cancer Initiative Framework, aiming to save 2.5 billion lives from breast cancer by 2040. The framework recommends early detection, timely diagnosis, and comprehensive management of the disease. Breast cancer is the most common adult cancer, with 95% of countries having it as the leading cause of female cancer deaths. However, survival remains inequitable, with 80% of deaths occurring in low- and middle-income countries.

Challenges associated with the devices

The Digital Breast Tomosynthesis (DBT) market faces several challenges, including high costs, specialized training for radiologists, potential radiation exposure concerns, regulatory hurdles, and limited reimbursement policies. These factors can hinder the growth and adoption of DBT, especially in smaller healthcare facilities and developing regions.

Market Segment Analysis

The global digital breast tomosynthesis market is segmented based on product type, application, end-user, and region.

The 2D/3D combination systems from the product type segment accounted for approximately 54.1% of the digital breast tomosynthesis market share

The 2D/3D combination systems from the product type segment accounted for approximately 54.1%. 2D/3D combination systems are essential in Digital Breast Tomosynthesis (DBT) for improving breast cancer screening and diagnosis. These systems combine traditional 2D mammography with advanced 3D tomosynthesis, providing a comprehensive view of breast tissue.

This combination leads to better detection rates, especially in dense breast tissue, and reduces false positives. It also minimizes callbacks and patient anxiety. These systems are increasingly preferred in clinical settings due to their ability to provide standard mammographic views and enhanced diagnostic capabilities in a single examination.

For instance, in November 2023, GE HealthCare launched MyBreastAI Suite, an all-in-one platform of AI apps, designed to aid clinicians in breast cancer detection and enhance workflow productivity. The suite integrates three iCAD applications, ProFound AI for DBT, SecondLook for 2D Mammography, and PowerLook Density Assessment.

Market Geographical Share

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to rising breast cancer incidence, FDA clearance, the region's developed healthcare infrastructure, increasing healthcare spending and other factors help the North American market is expected to maintain its dominance over the forecast period.

For instance, in November 2023, the Food and Drug Administration (FDA) granted 510(k) clearance for Lunit Insight DBT, an artificial intelligence (AI)-enabled modality that provides an adjunctive assessment of digital breast tomosynthesis (DBT) images.

Market Segmentation

By Product Type

• 2D/3D Combination systems
• Standalone 3D Systems

By Application

• Screenings
• Diagnostic

By End User

• Hospitals
• Diagnostic Centers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Market Competitive Landscape

The major global players in the market include Fujifilm, GE Healthcare, GMM (IMS Giotto), Hologic, Inc., Planmeca (Planmed), Siemens Healthineers, Philips Healthcare, AGFA Healthcare, Trivitron Healthcare, Carestream Health among others.

Key Developments

• In July 2024, LG Electronics (LG) is accelerating its B2B medical device business, expanding its lineup of diagnostic monitors with the new 21HQ613D-B, which was recently cleared by the U.S. Food and Drug Administration for sale in the U.S.

Why Purchase the Report?

• To visualize the global digital breast tomosynthesis market segmentation based on product type, application, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the digital breast tomosynthesis market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global digital breast tomosynthesis market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies